Gilead's HIV Prevention Drug Shows 96% Success Rate in Breakthrough Trial Results | GILD Stock News - StockTitan

Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow - Business Wire

From Fear to Hope: The HIV & Aids Journey Screening and Conversation - Miami's Community Newspapers

World AIDS Day 2024 - World Health Organization

Egypt and the Global Fund partner to strengthen health systems in the fight against HIV and tuberculosis, enhancing support for vulnerable communities - UNDP

A Gesture Larger Than Death: On Bill T. Jones’s AIDS Elegy “Still/Here” at 30 - Literary Hub

Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV - BioSpace

Inhibiting HIV by Host Cell Targeting Strategies - amfAR, The Foundation for AIDS Research

Feature Story - UNAIDS

When DREAMS Become Reality in Mozambique - CDC

Drug use among men having sex with men increases risk for HIV infection - vietnamnews.vn

Real World: San Francisco alum Judd Winick paid tribute to co-star Pedro Zamora three decades after his d - The Times of India

Betsey Johnson & Elton John AIDS Foundation Collaborate - Gotham | Modern Luxury

AIDS Healthcare Foundation Offering Free Monthly Testing on Both Campuses - Long Beach City College

Society for AIDS in Africa launches mentorship programme - Modern Ghana

Nigeria urgently needs to enhance its domestic financing mechanisms to sustain its HIV programmes – SAA - Modern Ghana

All About the World AIDS Day 2024 Theme - POZ

No outbreak, but docs flag HIV risk from tattoo needles - The Times of India

Egypt and the Global Fund partner to strengthen health systems in the fight against HIV and tuberculosis, enhancing support for vulnerable communities - UNDP

R.I.P. Cornelius Baker, Longtime HIV Strategist and Advocate for Black Gay Men - POZ

Characteristics and influencing factors of immunological non-responders in HIV-1-infected patients receiving antiretroviral therapy: a cross-sectional study in Guangxi - Nature.com

Funding gaps impede South Sudan’s HIV/AIDS fight. - Radio Tamazuj

Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV - Business Wire

Sweeping language introduced to modernize Ohio’s HIV laws proposed by an unlikely lawmaker - The Buckeye Flame

HIV/AIDS: Ekiti To End Mother To Child Transmission - Ekiti State Government

Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline - Business Wire

Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine - Media OutReach

AIDS Healthcare Foundation promotes condom use with ‘Just Use It’ campaign - Ad Age

Interior AIDS Association: Connecting communities to fight HIV - The Alaska 100

A Voice For People Living With HIV In The East And Southeast Asian Community - IN Magazine